Paper7945331
In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.
Lupo E and 3 others. Biochem Biophys Res Commun, 1994. Cited by 72 papers, by iCite.
Cite this record
ConductScience Library. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol. Papers, record 7945331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7945331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antioxidants | Major topic |
| Calcium Channel Blockers | Major topic |
| Copper | Major topic |
| Lipoproteins, LDL | Major topic |
| Vitamin E | Major topic |
| Adult | |
| Amlodipine | |
| Dihydropyridines | |
| Diltiazem | |
| Dose-Response Relationship, Drug | |
| Humans | |
| Isradipine | |
| Oxidation-Reduction | |
| Reference Values | |
| Thiobarbituric Acid Reactive Substances | |
| Verapamil |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34549160 | Quantitative Estimation of the Hydrogen-Atom-Donating Ability of 4-Substituted Hantzsch Ester Radical Cations. | ACS Omega | 2021 | https://conductscience.org/library/papers/34549160 | PubMed |
| 34070760 | Novel Combined Antioxidant Strategy against Hypertension, Acute Myocardial Infarction and Postoperative Atrial Fibrillation. | Biomedicines | 2021 | https://conductscience.org/library/papers/34070760 | PubMed |
| 33782898 | Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction. | Drug Deliv Transl Res | 2022 | https://conductscience.org/library/papers/33782898 | PubMed |
| 31878229 | Atherosclerosis and the Capillary Network; Pathophysiology and Potential Therapeutic Strategies. | Cells | 2019 | https://conductscience.org/library/papers/31878229 | PubMed |
| 31337127 | Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31337127 | PubMed |
| 29382065 | Electrospun Fibers as a Dressing Material for Drug and Biological Agent Delivery in Wound Healing Applications. | Bioengineering (Basel) | 2018 | https://conductscience.org/library/papers/29382065 | PubMed |
| 28123178 | Clinical roles of calcium channel blockers in ischemic heart diseases. | Hypertens Res | 2017 | https://conductscience.org/library/papers/28123178 | PubMed |
| 27900409 | Perspectives and challenges of antioxidant therapy for atrial fibrillation. | Naunyn Schmiedebergs Arch Pharmacol | 2017 | https://conductscience.org/library/papers/27900409 | PubMed |
| 27667708 | Drug Treatment of Hypertension: Focus on Vascular Health. | Drugs | 2016 | https://conductscience.org/library/papers/27667708 | PubMed |
| 26881016 | 1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative Stress. | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/26881016 | PubMed |
| 26446867 | Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction. | Psychopharmacology (Berl) | 2016 | https://conductscience.org/library/papers/26446867 | PubMed |
| 25237643 | Wound healing potential of topical amlodipine in full thickness wound of rabbit. | Jundishapur J Nat Pharm Prod | 2014 | https://conductscience.org/library/papers/25237643 | PubMed |
| 18406361 | Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability. | Biochim Biophys Acta | 2008 | https://conductscience.org/library/papers/18406361 | PubMed |
| 17051237 | Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus. | J Hum Hypertens | 2007 | https://conductscience.org/library/papers/17051237 | PubMed |
| 12023940 | Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism. | Br J Pharmacol | 2002 | https://conductscience.org/library/papers/12023940 | PubMed |
| 11817973 | Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. | Drugs | 2002 | https://conductscience.org/library/papers/11817973 | PubMed |
| 10981130 | Antihypertensive drugs and reversing of endothelial dysfunction in hypertension. | Curr Hypertens Rep | 2000 | https://conductscience.org/library/papers/10981130 | PubMed |
| 8924055 | Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals. | Cardiovasc Drugs Ther | 1996 | https://conductscience.org/library/papers/8924055 | PubMed |
| 8692742 | Nicanartine improves in vitro resistance of lipoproteins to oxidation. | Pharm Res | 1996 | https://conductscience.org/library/papers/8692742 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7945331
GET https://conductscience.org/api/papers/v1/7945331/authors